Navigation Links
Nuvo announces second quarter 2008 financial results
Date:7/31/2008

dian Pennsaid sales and an

additional $2.0 million through the issuance of a convertible

debenture. These transactions extend the Company's cash financial

runway beyond mid 2009 when it expects to receive U.S. FDA approval of

Pennsaid, a topical non-steroidal anti-inflammatory drug (NSAID) used

to treat the pain and stiffness associated with knee osteoarthritis.

"Quarter by quarter, we are steadily moving closer to our goal of achieving Pennsaid's approval in the U.S., while ensuring we have suitable cash resources beyond this milestone," said Henrich Guntermann, President and Chief Executive Officer, "At the same time, we are excited about our expanding pipeline, which we strengthened in the second quarter through internal research and development activities and by our agreement to in-license the exclusive rights to develop and commercialize a novel, early stage topical pain formulation."

Financial Results

(thousands of Three months Three months Six months Six months

Canadian dollars) ended ended ended ended

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

-------------------------------------------------------------------------

Revenue $ 2,085 $ 1,435 $ 4,321 $ 2,413

Net loss $ (2,864) $ (3,034) $ (5,135) $ (6,521)

-------------------------------------------------------------------------

Revenue for the three-months ended June 30, 2008 increased 45% to $2.1 million compared with $1.4 million for the three-months ended June 30, 2007. The significant increase is due primarily to a $0.6 million increase in Pennsaid product sales to the Company's Greek distributor and an increase in sales of WF10 based products. Revenue for the six-months ended June 30, 2008 inc
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
2. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
3. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
4. Hologic Announces Third Quarter Fiscal 2008 Operating Results
5. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
6. The Quantum Group Announces 2nd Statewide Contract
7. STERIS Corporation Announces Fiscal 2009 First Quarter Results
8. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
9. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
10. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
11. Align Technology Announces Second Quarter Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... According to the "Get Rid Tattoo ... a comprehensive guide that provides readers with safe and ... book also teaches them how to fade dark colored ... their own home for drastic results. , Vkool ... book includes step-by-step tutorials and product recommendations for treating ...
(Date:7/25/2014)... 26, 2014 PersonalInjurySolicitorsIreland, a legal ... to people who have suffered from a variety ... both their new company, and a website, ... new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law ... of the company is always on the client, ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 According ... Monitoring Market by Product (vibration monitoring, thermography, ultrasound ... signature analysis), Component, Application and Geography - Global ... the machine health monitoring market is expected to ... 2014 to 2020. , Browse 117 market data ...
(Date:7/25/2014)... 2014 As reported by the New Orleans ... Increasing (7/3), the state of Louisiana has recently seen ... even than cocaine. Officials believe the increase is due to ... “form” of marijuana. However, both doctors and police confirm that ... as to call it “poison,” doctors have acknowledged that the ...
(Date:7/25/2014)... Gerontological Society of America (GSA) the ... of aging has chosen Heather M. Young, ... Davis, as the 2014 recipient of the Doris ... honor, presented by GSA,s Health Sciences Section, is ... recognition of outstanding and sustained contribution to gerontological ...
Breaking Medicine News(10 mins):Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2
... the journal Clinical Cardiology reveals that a Super Bowl ... in both men and women and in older individuals. , Sports ... the team loses, it can cause some degree of emotional stress. ... Institute, Good Samarian Hospital and Keck School of Medicine at USC ...
... real estate developer Douglas Rosenberg says he has a new ... Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist ... Bredesen, MD has the correct take on how to thwart ... The two have formed a unique partnership aimed at developing ...
... 29 (HealthDay News) -- Dry eye syndrome is common in ... heat, says an eye expert. Symptoms include pain, blurred ... as the eyes try to compensate for the dryness, explains ... and allergies can cause watery eyes, differentiating the two conditions ...
... Randy Dotinga HealthDay Reporter , FRIDAY, Jan. 28 ... percent of patients are considered difficult, and they,re more likely ... of the equation: Researchers also report that older doctors and ... patients. "The patients who have these kinds of problems ...
... that appears to contribute to blood vessel damage in ... Washington University School of Medicine in St. Louis. ... of the nearly 26 million Americans with the disease ... vision loss because of damaged vessels. Reporting in ...
... stress management techniques before prostate cancer surgery may help ... as well as aid in lowering mood disturbance, according ... of Texas MD Anderson Cancer Center. The ... journal Psychosomatic Medicine . It,s the first to ...
Cached Medicine News:Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 2Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 3Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 4Health News:Dry Eye Syndrome Common in Winter 2Health News:Docs Rate Almost 1 in 5 Patients as 'Difficult': Study 2Health News:Researchers discover root cause of blood vessel damage in diabetes 2Health News:Researchers discover root cause of blood vessel damage in diabetes 3Health News:Researchers discover root cause of blood vessel damage in diabetes 4Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3
(Date:7/25/2014)... 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... update and report second quarter 2014 financial results before ... 1, 2014. That same day, Arena will host a ... (5:30 a.m. Pacific Time). The conference ... callers and 914.495.8552 for international callers. Please specify to ...
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
(Date:7/24/2014)... 2014  Uroplasty, Inc. (NASDAQ: UPI ), ... markets innovative proprietary products to treat voiding dysfunctions, ... first quarter ended June 30, 2014.  Global ... System grew 19% to $4.1 million, as compared ... the prior year.  Total revenue for the fiscal ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... FRANCISCO, Jan. 29 Inverseon, Inc.,( http://www.inverseon.com ) ... trial in asthma., In the article by ... 21, (2008), pp. 134-141, entitled, "The safety and,effects ... open-label pilot,study," mild asthmatics were treated for 9 ...
... New Patient Data Posted Online Shows Improvements Across ... The Cystic Fibrosis,Foundation reported today that key indicators ... lung function and nutritional status -- are,rising nationwide ... fact, the outlook for people with CF continues ...
Cached Medicine Technology:Inverseon Announces Positive Phase IIa Asthma Study 2Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes 2
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: male: 3.5 - 7.0 mg/dL and female: 2.5 - 6.0 mg/dL. Available with calibrator and number of test 500....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
Medicine Products: